Amneal Taps Strides To Add More Competition To US Vascepa Market

Originator Amarin Claims Continued Market Lead – Three Years After First Generic Launch

 
• By Dean Rudge

Amneal has in-licensed Strides’ generic version of Vascepa to compete with the several ANDA products already on the market.

heart shape of Fish oil, soft capsule, omega, supplement isolated on white background,healthy product concept - Image
• Source: Shutterstock

More from Deals

More from Business